BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 38725845)

  • 1. Multi-Omics profiling identifies aldehyde dehydrogenase 2 as a critical mediator in the crosstalk between Treg-mediated immunosuppression microenvironment and hepatocellular carcinoma.
    Liu ZY; Lin XH; Guo HY; Shi X; Zhang DY; Sun JL; Zhang GC; Xu RC; Wang F; Yu XN; Wang D; Weng SQ; Shen XZ; Liu TT; Dong L; Zhu JM
    Int J Biol Sci; 2024; 20(7):2763-2778. PubMed ID: 38725845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intratumoral stem-like CCR4+ regulatory T cells orchestrate the immunosuppressive microenvironment in HCC associated with hepatitis B.
    Gao Y; You M; Fu J; Tian M; Zhong X; Du C; Hong Z; Zhu Z; Liu J; Markowitz GJ; Wang FS; Yang P
    J Hepatol; 2022 Jan; 76(1):148-159. PubMed ID: 34689996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SLC3A2, as an indirect target gene of ALDH2, exacerbates alcohol-associated liver cancer via the sphingolipid biosynthesis pathway.
    Xia P; Liu DH; Wang D; Wen GM; Zhao ZY
    Free Radic Biol Med; 2023 Sep; 206():125-133. PubMed ID: 37406742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Research Progress on the Correlation between Acetaldehyde Dehydrogenase 2 and Hepatocellular Carcinoma Development.
    Yang D; Hu Y; Yang J; Tao L; Su Y; Wu Y; Yao Y; Wang S; Ye S; Xu T
    J Pharmacol Exp Ther; 2024 Apr; 389(2):163-173. PubMed ID: 38453527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aldehyde dehydrogenase 2 polymorphism for development to hepatocellular carcinoma in East Asian alcoholic liver cirrhosis.
    Abe H; Aida Y; Seki N; Sugita T; Tomita Y; Nagano T; Itagaki M; Sutoh S; Nagatsuma K; Itoh K; Matsuura T; Aizawa Y
    J Gastroenterol Hepatol; 2015 Sep; 30(9):1376-83. PubMed ID: 25778454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatocellular carcinoma and macrophage interaction induced tumor immunosuppression via Treg requires TLR4 signaling.
    Yang J; Zhang JX; Wang H; Wang GL; Hu QG; Zheng QC
    World J Gastroenterol; 2012 Jun; 18(23):2938-47. PubMed ID: 22736917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aldehyde dehydrogenase-2 (ALDH2) opposes hepatocellular carcinoma progression by regulating AMP-activated protein kinase signaling in mice.
    Hou G; Chen L; Liu G; Li L; Yang Y; Yan HX; Zhang HL; Tang J; Yang YC; Lin X; Chen X; Luo GJ; Zhu Y; Tang S; Zhang J; Liu H; Gu Q; Zhao LH; Li Y; Liu L; Zhou W; Wang H
    Hepatology; 2017 May; 65(5):1628-1644. PubMed ID: 28027570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GDF15 induces immunosuppression via CD48 on regulatory T cells in hepatocellular carcinoma.
    Wang Z; He L; Li W; Xu C; Zhang J; Wang D; Dou K; Zhuang R; Jin B; Zhang W; Hao Q; Zhang K; Zhang W; Wang S; Gao Y; Gu J; Shang L; Tan Z; Su H; Zhang Y; Zhang C; Li M
    J Immunother Cancer; 2021 Sep; 9(9):. PubMed ID: 34489334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of acetaldehyde dehydrogenase 2 in the pathogenesis of liver diseases.
    Wu YC; Yao Y; Tao LS; Wang SX; Hu Y; Li LY; Hu S; Meng X; Yang DS; Li H; Xu T
    Cell Signal; 2023 Feb; 102():110550. PubMed ID: 36464104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cystathionine β-synthase mediated PRRX2/IL-6/STAT3 inactivation suppresses Tregs infiltration and induces apoptosis to inhibit HCC carcinogenesis.
    Zhou YF; Song SS; Tian MX; Tang Z; Wang H; Fang Y; Qu WF; Jiang XF; Tao CY; Huang R; Zhou PY; Zhu SG; Zhou J; Fan J; Liu WR; Shi YH
    J Immunother Cancer; 2021 Aug; 9(8):. PubMed ID: 34413167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aldehyde dehydrogenase expression may be a prognostic biomarker and associated with liver cirrhosis in patients resected for hepatocellular carcinoma.
    Pommergaard HC; Rasmussen A; Hillingsø J; Kugler JM
    Surg Oncol; 2022 Mar; 40():101677. PubMed ID: 34896911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective recruitment of regulatory T cell through CCR6-CCL20 in hepatocellular carcinoma fosters tumor progression and predicts poor prognosis.
    Chen KJ; Lin SZ; Zhou L; Xie HY; Zhou WH; Taki-Eldin A; Zheng SS
    PLoS One; 2011; 6(9):e24671. PubMed ID: 21935436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multigenerational maternal obesity increases the incidence of HCC in offspring via miR-27a-3p.
    Sun Y; Wang Q; Zhang Y; Geng M; Wei Y; Liu Y; Liu S; Petersen RB; Yue J; Huang K; Zheng L
    J Hepatol; 2020 Sep; 73(3):603-615. PubMed ID: 32593682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-15a/16-1 Prevents Hepatocellular Carcinoma by Disrupting the Communication Between Kupffer Cells and Regulatory T Cells.
    Liu N; Chang CW; Steer CJ; Wang XW; Song G
    Gastroenterology; 2022 Feb; 162(2):575-589. PubMed ID: 34678217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic polymorphisms of ALDH2 and ADH2 are not associated with risk of hepatocellular carcinoma among East Asians.
    Zhou D; Xiao L; Zhang Y; Xian J; Jiang J; Zong W; Huang Z; Yang Y
    Tumour Biol; 2012 Jun; 33(3):841-6. PubMed ID: 22231434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GITR ligation enhances functionality of tumor-infiltrating T cells in hepatocellular carcinoma.
    van Beek AA; Zhou G; Doukas M; Boor PPC; Noordam L; Mancham S; Campos Carrascosa L; van der Heide-Mulder M; Polak WG; Ijzermans JNM; Pan Q; Heirman C; Mahne A; Bucktrout SL; Bruno MJ; Sprengers D; Kwekkeboom J
    Int J Cancer; 2019 Aug; 145(4):1111-1124. PubMed ID: 30719701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delineation of an immunosuppressive gradient in hepatocellular carcinoma using high-dimensional proteomic and transcriptomic analyses.
    Chew V; Lai L; Pan L; Lim CJ; Li J; Ong R; Chua C; Leong JY; Lim KH; Toh HC; Lee SY; Chan CY; Goh BKP; Chung A; Chow PKH; Albani S
    Proc Natl Acad Sci U S A; 2017 Jul; 114(29):E5900-E5909. PubMed ID: 28674001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intratumoral regulatory T cells with higher prevalence and more suppressive activity in hepatocellular carcinoma patients.
    Wu H; Chen P; Liao R; Li YW; Yi Y; Wang JX; Cai XY; He HW; Jin JJ; Cheng YF; Fan J; Sun J; Qiu SJ
    J Gastroenterol Hepatol; 2013 Sep; 28(9):1555-64. PubMed ID: 23517245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatoma cell-derived leptin downregulates the immunosuppressive function of regulatory T-cells to enhance the anti-tumor activity of CD8+ T-cells.
    Wei R; Hu Y; Dong F; Xu X; Hu A; Gao G
    Immunol Cell Biol; 2016 Apr; 94(4):388-99. PubMed ID: 26639061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alcohol dehydrogenase-2 and aldehyde dehydrogenase-2 genotypes, alcohol drinking and the risk of primary hepatocellular carcinoma in a Chinese population.
    Ding J; Li S; Wu J; Gao C; Zhou J; Cao H; Su PS; Liu Y; Zhou X; Chang J
    Asian Pac J Cancer Prev; 2008; 9(1):31-5. PubMed ID: 18439068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.